Middle meningeal artery embolization for chronic subdural hematoma: a systematic review
BackgroundChronic subdural hematoma (cSDH) is one of the most common diseases in neurosurgery. Middle meningeal artery embolization (MMAE) is reportedly an option to prevent recurrence or avoid surgery in patients with cSDH. This study was performed to review the evidence on MMAE for cSDH and evalua...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-10-01
|
| Series: | Frontiers in Neurology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2023.1259647/full |
| _version_ | 1797663001554190336 |
|---|---|
| author | Yoshihiro Omura Taichi Ishiguro |
| author_facet | Yoshihiro Omura Taichi Ishiguro |
| author_sort | Yoshihiro Omura |
| collection | DOAJ |
| description | BackgroundChronic subdural hematoma (cSDH) is one of the most common diseases in neurosurgery. Middle meningeal artery embolization (MMAE) is reportedly an option to prevent recurrence or avoid surgery in patients with cSDH. This study was performed to review the evidence on MMAE for cSDH and evaluate its safety, efficacy, indications, and feasibility.MethodsWe systematically reviewed the literature according to the PRISMA guidelines using an electronic database. The search yielded 43 articles involving 2,783 patients who underwent MMAE.ResultsThe hematoma resolution, recurrence, and retreatment rates in the MMAE-alone treatment group (n = 815) were 86.7%, 6.3%, and 9.6%, respectively, whereas those in the prophylactic MMAE with combined surgery group (n = 370) were 95.6%, 4.4%, and 3.4%, respectively. The overall MMAE-related complication rate was 2.3%.ConclusionThis study shows that MMAE alone is, although not immediate, as effective as evacuation surgery alone in reducing hematoma. The study also shows that combined treatment has a lower recurrence rate than evacuation surgery alone. Because MMAE is a safe procedure, it should be considered for patients with cSDH, especially those with a high risk of recurrence. |
| first_indexed | 2024-03-11T19:07:15Z |
| format | Article |
| id | doaj.art-728e289c6af845ac9e3d41821101e0be |
| institution | Directory Open Access Journal |
| issn | 1664-2295 |
| language | English |
| last_indexed | 2024-03-11T19:07:15Z |
| publishDate | 2023-10-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Neurology |
| spelling | doaj.art-728e289c6af845ac9e3d41821101e0be2023-10-10T04:25:13ZengFrontiers Media S.A.Frontiers in Neurology1664-22952023-10-011410.3389/fneur.2023.12596471259647Middle meningeal artery embolization for chronic subdural hematoma: a systematic reviewYoshihiro OmuraTaichi IshiguroBackgroundChronic subdural hematoma (cSDH) is one of the most common diseases in neurosurgery. Middle meningeal artery embolization (MMAE) is reportedly an option to prevent recurrence or avoid surgery in patients with cSDH. This study was performed to review the evidence on MMAE for cSDH and evaluate its safety, efficacy, indications, and feasibility.MethodsWe systematically reviewed the literature according to the PRISMA guidelines using an electronic database. The search yielded 43 articles involving 2,783 patients who underwent MMAE.ResultsThe hematoma resolution, recurrence, and retreatment rates in the MMAE-alone treatment group (n = 815) were 86.7%, 6.3%, and 9.6%, respectively, whereas those in the prophylactic MMAE with combined surgery group (n = 370) were 95.6%, 4.4%, and 3.4%, respectively. The overall MMAE-related complication rate was 2.3%.ConclusionThis study shows that MMAE alone is, although not immediate, as effective as evacuation surgery alone in reducing hematoma. The study also shows that combined treatment has a lower recurrence rate than evacuation surgery alone. Because MMAE is a safe procedure, it should be considered for patients with cSDH, especially those with a high risk of recurrence.https://www.frontiersin.org/articles/10.3389/fneur.2023.1259647/fullembolizationchronic subdural hematomamiddle meningeal arteryrecurrenceendovascular |
| spellingShingle | Yoshihiro Omura Taichi Ishiguro Middle meningeal artery embolization for chronic subdural hematoma: a systematic review Frontiers in Neurology embolization chronic subdural hematoma middle meningeal artery recurrence endovascular |
| title | Middle meningeal artery embolization for chronic subdural hematoma: a systematic review |
| title_full | Middle meningeal artery embolization for chronic subdural hematoma: a systematic review |
| title_fullStr | Middle meningeal artery embolization for chronic subdural hematoma: a systematic review |
| title_full_unstemmed | Middle meningeal artery embolization for chronic subdural hematoma: a systematic review |
| title_short | Middle meningeal artery embolization for chronic subdural hematoma: a systematic review |
| title_sort | middle meningeal artery embolization for chronic subdural hematoma a systematic review |
| topic | embolization chronic subdural hematoma middle meningeal artery recurrence endovascular |
| url | https://www.frontiersin.org/articles/10.3389/fneur.2023.1259647/full |
| work_keys_str_mv | AT yoshihiroomura middlemeningealarteryembolizationforchronicsubduralhematomaasystematicreview AT taichiishiguro middlemeningealarteryembolizationforchronicsubduralhematomaasystematicreview |